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30% decrease in end-stage animals (relative to control). Increased 
puncta formation relative to the control average is consistent with 
the notion that OPTN expression is upregulated for its ability to 
bind cargo.
Interestingly, and despite an OPTN conformation that favored 
cargo transport, colocalization with autophagic vessels was 
signifi cantly diminished relative to control average. We observed a 
32% decrease at 24 hours and a 37% decrease at 5 days. Although 
there are many possible explanations for decreased colocalization, 
one likelihood is that OPTN and LC3 migrate to different cargo.
In summary, we have provided the fi rst evidence that OPTN is 
enriched in clinically relevant PD regions and that distribution 
is altered in preclinical environmental PD models. Signifi cant 
impairment to OPTN–LC3 colocalization also may be indicative of 
the impaired autophagy observed in PD. Ultimately, understanding 
how PD defi ciencies manifest themselves in ways beyond motor 
dysfunction could allow clinicians to recognize more quickly cases 
in order to incorporate appropriate intervention strategies prior to 
neurodegeneration.
Research advisor Jason Cannon writes: “Aberrant autophagy 
has been linked to the pathogenesis of PD. Yet, where in the brain 
and at which disease stages that autophagy disruptions occur 
is unknown. Joey’s work has begun to make some important 
advances in these areas. In animal models of PD, Joey has helped 
to show that key proteins involved in autophagy are altered in 
expression and cellular localization prior to cell death, and also 
that brain regions involved in both motor and nonmotor symptoms 
of PD are affected. His data has implications in understanding the 
pathogenesis of Parkinson’s disease and also, potentially, in the 
identifi cation of new therapeutic pathways.”




Parkinson’s disease (PD) is a neurodegenerative disease 
characterized by a resting tremor and slowed movement. These 
motor defi cits result from cell death in a brain region called the 
substantia nigra (SN). Additionally, insoluble clusters of toxic 
proteins, termed Lewy Bodies (LB), develop in the brain. Lewy 
Body accumulation is reported to increase in scope and severity 
as PD progresses and, notably, does not affect the SN until 
halfway through disease progression. Therefore, according to the 
hypothesis that LB overload ultimately contributes to cell death, 
clinical intervention of PD does not occur until cell death in the SN 
is imminent. 
Autophagy is the cellular process responsible for degrading dys-
functional proteins, which is compromised in PD. Since the failure 
of this critical pathway precedes LB development, elucidating the 
mechanisms by which autophagy is impaired could allow for earli-
er attempts targeted at attenuating LB proliferation. 
Optineurin (OPTN, green) is a protein critical for autophagy, where 
it acts as a cargo adapter by linking substrates for degradation to 
the site of autophagic breakdown. Despite mutations in the OPTN 
gene being linked to glaucoma and ALS, the protein has received 
minimal attention. Given the overlap between disease pathology 
and the cellular role of OPTN, I sought to examine OPTN in vivo 
(in a living organism).
Rotenone is a naturally occurring pesticide that has been exten-
sively characterized for its ability to recapitulate PD pathology; 
in our study, rats received injections for 24 hours, 5 days, or until 
the onset of behavioral defi cits (typically approximately 7 days 
later, which was associated with overt neurodegeneration). We 
then performed quantitative immunofl uorescence on rat tissues in 
order to evaluate changes to OPTN’s distributional conformation 
within cells. Additionally, we quantifi ed OPTN colocalization with 
a marker for autophagic vacuoles (LC3, red).
Immediately following rotenone administration, we saw signifi cant 
alterations to OPTN distribution in cells. This change favored 
the formation of bright circular dots, termed puncta, by 24% 
relative to control animals. In subsequent stages, the percent of 
OPTN existing as puncta fell to a 1% increase at 5 days and a 
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A-D) Representative images 
of OPTN (green) and LC3 (red) 
expression in control, 24 hour-, 
5 day-, and end-stage animals, 
respectively; signi cant increases 
to the fraction of cellular OPTN 
in punctate conformation and in 
cellular LC3 expression are ob-
served at 24 hours; n = 120–170 
cells analyzed/group; signi -
cance is p < 0.05 for all groups.
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